The Current Ratio of Fate Therapeutics Inc (FATE) is
5.79.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
5.79
|
| 2024-12-31 |
7.58
|
| 2023-12-31 |
8.48
|
| 2022-12-31 |
4.40
|
| 2021-12-31 |
7.79
|
| 2020-12-31 |
5.77
|
| 2019-12-31 |
8.17
|
| 2018-12-31 |
7.52
|
| 2017-12-31 |
9.33
|
| 2016-12-31 |
6.14
|
| Ticker |
Name |
Value |
|
TGTX
|
TG Therapeutics, Inc.
|
6.25
|
|
TPTX
|
Turning Point Therapeutics Inc
|
21.08
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
ALXO
|
ALX Oncology Holdings Inc
|
7.05
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
ARNA
|
Arena Pharmaceuticals Inc
|
8.59
|
|
IGMS
|
IGM Biosciences LLC
|
5.11
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
5.08
|
|
BHVN
|
Biohaven Ltd.
|
3.18
|
|
FGEN
|
FibroGen Inc
|
1.47
|
|
RVMD
|
Revolution Medicines, Inc.
|
7.14
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
3.83
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
3.81
|
|
BPMC
|
Blueprint Medicines Corp
|
2.85
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
4.66
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
2.32
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
3.14
|
|
CCXI
|
Churchill Capital Corp XI
|
8.13
|
|
MRTX
|
Mirati Therapeutics Inc
|
6.96
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
ASND
|
Ascendis Pharma A/S
|
1.04
|
|
KOD
|
Kodiak Sciences Inc.
|
4.72
|
|
VIE
|
Viela Bio Inc
|
8.45
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
7.93
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
IOVA
|
Iovance Biotherapeutics Inc
|
3.20
|
|
LEGN
|
Legend Biotech Corporation
|
1.96
|
|
RLAY
|
Relay Therapeutics, Inc.
|
22.61
|
|
SANA
|
Sana Biotechnology, Inc.
|
1.89
|
|
XLRN
|
Acceleron Pharma Inc
|
14.84
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
CRSP
|
CRISPR Therapeutics AG
|
13.32
|